Boxlight Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Boxlight Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $25.74M | Aug 16, 2018 |
| FY2017 | Dec 31, 2016 | $20.37M | Aug 16, 2018 |
| FY2016 | Dec 31, 2015 | $3.38M | Oct 10, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $109.25M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $135.89M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $176.72M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $221.78M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $185.18M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $54.89M | Apr 13, 2022 |
| FY2020 | Dec 31, 2019 | $33.03M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $37.84M | May 13, 2020 |
| FY2020 | Jan 31, 2018 | $250.0K | Mar 31, 2021 |
| FY2018 | Dec 31, 2017 | $25.74M | Mar 28, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.63M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $46.94M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $63.30M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $64.87M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $46.53M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $9.87M | Apr 13, 2022 |
| FY2020 | Dec 31, 2019 | $8.94M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $8.65M | May 13, 2020 |
| FY2018 | Dec 31, 2017 | $6.41M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $7.41M | Aug 16, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($23.81M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($28.34M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($39.16M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($3.74M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($13.80M) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($16.15M) | Apr 13, 2022 |
| FY2020 | Dec 31, 2019 | ($9.40M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($7.18M) | May 13, 2020 |
| FY2018 | Dec 31, 2017 | ($6.54M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($2.06M) | Aug 16, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($16.37M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($19.47M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($26.30M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $3.05M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($2.57M) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($12.71M) | Apr 13, 2022 |
| FY2020 | Dec 31, 2019 | ($8.06M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($7.00M) | May 13, 2020 |
| FY2018 | Dec 31, 2017 | ($7.24M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($1.29M) | Aug 16, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.27M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $4.13M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $3.16M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.48M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $1.83M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.42M | Apr 13, 2022 |
| FY2020 | Dec 31, 2019 | $1.23M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $671.7K | May 13, 2020 |
| FY2018 | Dec 31, 2017 | $465.9K | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.01M | Aug 16, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.34M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($439.0K) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $11.58M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.19M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($2.33M) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($4.66M) | Apr 13, 2022 |
| FY2020 | Dec 31, 2019 | ($4.26M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($3.77M) | May 13, 2020 |
| FY2018 | Dec 31, 2017 | ($1.34M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $2.37M | Aug 16, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $102.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $506.0K | Apr 15, 2026 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $97.54M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $115.31M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $161.77M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $195.40M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $201.44M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $139.95M | Apr 13, 2022 |
| FY2020 | Dec 31, 2019 | $20.47M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $21.27M | May 13, 2020 |
| FY2018 | Dec 31, 2017 | $20.45M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $19.12M | Aug 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $96.29M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $99.69M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $116.51M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $114.99M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $119.63M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $66.61M | Apr 13, 2022 |
| FY2020 | Dec 31, 2019 | $21.12M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $13.30M | May 13, 2020 |
| FY2018 | Dec 31, 2017 | $11.40M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $17.01M | Aug 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.26M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($12.90M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | $16.75M | Apr 15, 2026 |
| FY2024 | Dec 31, 2022 | $51.89M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $53.30M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $44.47M | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | ($647.0K) | Apr 13, 2022 |
| FY2020 | Dec 31, 2018 | $7.97M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $9.05M | May 13, 2020 |
| FY2018 | Dec 31, 2016 | $2.11M | Mar 28, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | Mar 28, 2025 |
| FY2024 | Dec 31, 2023 | $0 | Mar 28, 2025 |
| FY2024 | Dec 31, 2022 | $25.09M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $26.04M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $22.74M | Mar 17, 2023 |
| FY2020 | Dec 31, 2019 | $4.72M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $4.72M | May 13, 2020 |
| FY2018 | Dec 31, 2017 | $4.18M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $4.18M | Aug 16, 2018 |
| FY2016 | Dec 31, 2015 | $44.9K | Oct 10, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($156.42M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($132.61M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($104.28M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($65.04M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($61.30M) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($47.50M) | Apr 13, 2022 |
| FY2020 | Dec 31, 2019 | ($31.35M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($19.21M) | May 13, 2020 |
| FY2018 | Dec 31, 2017 | ($12.03M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($5.49M) | Aug 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.37M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $8.01M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $17.25M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $14.59M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $17.94M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $13.46M | Apr 13, 2022 |
| FY2020 | Dec 31, 2019 | $1.17M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $901.5K | May 13, 2020 |
| FY2018 | Dec 31, 2017 | $2.01M | Mar 28, 2019 |
| FY2018 | Dec 31, 2016 | $456.5K | Mar 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.15M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $37.15M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $40.17M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $44.62M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $51.94M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $24.65M | Apr 13, 2022 |
| FY2019 | Dec 31, 2019 | $1.20M | May 13, 2020 |
| FY2018 | Dec 31, 2018 | $3.01M | Mar 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (39) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | (90) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | (21) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 13, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (39) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | (90) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | (21) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 13, 2022 |